Quotes: MENA   Enter Symbol: NewsLetter: Search: advanced

New drug to control diabetes launched  Join our daily free Newsletter

MENAFN - Arab News - 09/05/2014
No. of Ratings : 0
Add to Mixx!



(MENAFN - Arab News) More than 300 doctors from the kingdom attended the launch of a revolutionary new treatment for type 2 diabetes held in dubai over the weekend.

the launch of the product victoza (liraglutide) was announced by novo nordisk in dubai.

the medicine taken once daily at any fixed time irrespective of meals under prescription by specialist will change the course of the disease for better results and is available at stores throughout the kingdom.

'the launch of victoza is major news for saudi arabia" said vikrant shrotriya general manager of novo nordisk gulf. 'specialist in the kingdom will now have a therapy that targets the underlying problems of the disease inspiring a sense of control."

'saudi arabia has around around 3.6 million diabetics above the age of 20 while a similar number of people are pre-diabetic" he said.

diabetes is a dangerous condition and elevated blood sugar very often leads to the disease.

'victoza is a significant treatment option for patients with type 2 diabetes. it constutes an important new addition to the portfolio which is designed to support our mission to defeat the deadly disease" he said.



'this is why we are proud to make victoza available to patients in the kingdom."

victoza provides excellent glycemic control and delays disease progression in type 2 diabetes patients while aiding lasting weight loss.

victoza works with the body to lower blood sugar levels by boosting the release of insulin only when needed. these unique benefits result in blood sugar control combined with a reduced risk of blood sugar levels dropping too low.

victoza marks a decisive step forward for people with type 2 diabetes many of whom are overweight. 'type 2 diabetes often coexists with other high-risk conditions such as high blood pressure high cholesterol and obesity which add to the cardiovascular risk" said waleed abdel fattah medical director of novo nordisk gulf.

'victoza provides the answer for people to control diabetes and reduce the risk factors that may lead to development of complications."


 


Arab News




  MENA News Headlines
 Sep 30 2016 - Italy's Eni confirms renewable energy deal with EgyptMENAFN
(MENAFN) Italian oil Eni agreed a common strategy with Egypt to construct renewable energy projects in the country.Moreover, the first project will be a solar plant in Sinai with output of 50 MW, ...

 Sep 30 2016 - Oman's budget deficit reaches USD10.83bn in H1MENAFN
(MENAFN) Oman's budget deficit increased and crossed the RO4bn mark for Jan-July period this year as government revenue continued to hurt by weak oil prices.Meanwhile, the deficit grew by 68 percent ...

 Sep 30 2016 - UAE hotels to cut costs by 20pctMENAFN
(MENAFN) Hotels in the UAE could cut their costs by more than 20 percent by reducing their energy and water consumption.Moreover, hotels with poor environmental policies consume three times more ...

 Sep 29 2016 - Kimberly process chair steps up momentum on Africa initiativeMENAFN Press
(MENAFN Press) Zimbabwe was the next stop on his extensive tour of African States, to give Africa a Voice, for which the Kimberley Process was originally intended. In Harare, the KP Chair met with ...

 Sep 29 2016 - Global Virtual Reality Market 2016 Share, Trend, Segmentation and Forecast To 2020MENAFN Press
(MENAFN Press) Global Virtual Reality Market 2016 Share, Trend, Segmentation and Forecast To 2020 next five years in an average of 106% CAGR; by 2020 over 430 billion products will be sold, and 21 ...

 Sep 29 2016 - NY Gov. Cuomo's Justice Center a Corruption SchemeMENAFN Press
(MENAFN Press) NY Gov. Cuomo's Justice Center a Corruption Scheme Jonathan Carey "Champion for the Disabled" Born September 12,1993 Killed by caregivers on February 15,2007 The corruption is ...

 Sep 29 2016 - Solving the last jigsaws to minimize risks, optimize costs and accelerate commercialization at Biosimilars North AmericaMENAFN Press
(MENAFN Press) Solving the last jigsaws to minimize risks, optimize costs and accelerate commercialization at Biosimilars North America The 3rd annual Biosimilars North America by popular demand, ...

 Sep 29 2016 - Haptic Interface Market 2016 market Share, Current and Future Players, Analysis and Forecast to 2022.MENAFN Press
(MENAFN Press) Haptic Interface Market 2016 market Share, Current and Future Players, Analysis and Forecast to 2022. Global Haptic Interface Market Information, by Components (Hardware, Software), ...

 Sep 29 2016 - Cold Forging Machine: Consumption, Demand, Sales, Competitor and Forecast 2016 2021MENAFN Press
(MENAFN Press) Cold Forging Machine: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2021 Cold Forging Machine Global Market 2016 Analysis and Forecast to 2021 PUNE, INDIA, September ...

 Sep 29 2016 - Global Wind Power Market Top Manufactures, Market Demands, Trends, Industry Growth Analysis & Forecast 2021MENAFN Press
(MENAFN Press) Global Wind Power Market Top Manufactures, Market Demands, Trends, Industry Growth Analysis & Forecast 2021 Global Wind Power Market Information Report by Application (Residential ...

more...


 





Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

Search News
Market Indices
Quotes & Charts

Global Indices
Arab Indices

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Economic Calendar
Financial Glossary


Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2014 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help